Dermatologic toxicities to inhibitors of cyclin-dependent kinases CDK 4 and 6: An updated review for clinical practice.

Cyclin-dependent kinase (CDK) 4/6 inhibitors (palbociclib, ribociclib and abemaciclib) have revolutionized the treatment of metastatic breast carcinoma. They currently form the first-line treatment, in combination with endocrine agents, for the management of locally advanced or metastatic hormone receptor-positive (HR + ), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, the largest subtype of breast carcinoma. CDK 4/6 inhibitors have shown comparable efficacy outcomes with predictable and manageable adverse events. In this setting, dermatologic toxicity appears to be relatively frequent, accounting for up to 15% of all reported adverse events. It is usually mild to moderate in intensity and does not normally constitute a dose-limiting toxicity. The range of dermatologic adverse events includes both non-specific entities (maculopapular rash, pruritus, alopecia) and more characteristic toxicities related to CDK4/6 inhibitors, such as vitiligo-like lesions or cutaneous lupus erythematosus. Finally, more severe or life-threatening skin reactions can occasionally occur. The main dermatologic manifestations associated with CDK4/6 inhibitors, as well as management thereof, are described in this comprehensive review.

[Bullous dermatitis with multinucleated keratinocytes in dermatitis artefacta: A case report]. / Dermatose bulleuse avec kératinocytes multinucléés révélant une dermatose factice : à propos d'un cas et revue de la littérature.

We report the case of a 13-year-old young lady with a one year reccuring bullous dermatitis history for which the diagnostic hypothesis of dermatitis arterfacta was made. This hypothesis was made by the pathologist, without it being suggested by the dermatologist, after observing singular histological lesions coresponding to a cutaneous blister associated with epidermic necrosis with multinucleated keratinocytes. When dermatitis artefacta is suspected, a biopsy is usually conducted to rule out differential diagnosis such as auto-immmune dermatitis when there is a blister. Confession from patients is rarely obtained. Therefore, having positive histogical clues for dermatitis artefacta would be of a great use to help making the diagnosis in difficult cases.

Dermatitis herpetiforme y enfermedad celíaca / Dermatitis herpetiformis and celiac disease

La dermatitis herpetiforme (DH) es una enfermedad crónica y ampollar caracterizada por la presencia de lesiones intensamente pruriginosas, de ubicación característica, y por asociarse en todos los casos a enfermedad celíaca (EC) (sintomática o no). Ambas entidades se consideran una expresión, en diferentes órganos, de hipersensibilidad al gluten. Se presenta una serie de cuatro pacientes de sexo femenino, con un promedio de 46 años, que consultaron por la aparición de pápulas, lesiones erosivocostrosas, excoriaciones y ampollas, pruriginosas, localizadas predominantemente en los codos, las rodillas y el dorso superior. Referían brotes intermitentes con un tiempo de evolución de entre 6 meses y 10 años. Se realizó una biopsia cutánea y estudio histopatológico que evidenció la presencia de una dermatosis ampollar subepidérmica con neutrófilos e IFD positiva en tres de las pacientes, y que confirmó el diagnóstico de dermatitis herpetiforme. Los hallazgos de laboratorio y la videoendoscopia digestiva alta con toma de biopsia fueron compatibles, en todos los casos, con enfermedad celíaca. Se les indicó dieta libre de gluten (DLG) a todas las pacientes; en una de ellas fue suficiente para lograr la remisión completa de las lesiones después de 3 meses; las tres restantes requirieron tratamiento con dapsona para controlar la enfermedad (AU)

Dermatitis herpetiformis (DH) is a chronic, bullous disease, which is characterized by intensely pruritic lesions, property location and diagnosis in all cases of celiac disease (CD) (symptomatic or not). Both entities are considered expression in different organs of hypersensitivity to gluten. A series of four female patients is presented with an average of 46 years who consulted by the appearance of papules, erosivocostrosas injuries, abrasions and blisters, itchy, localized predominantly on elbows, knees and upper back. Intermittent outbreaks concerned with evolution time between 6 months and 10 years. IFD positive skin biopsy and histopathological study showed subepidermal bullous dermatosis with neutrophils was performed, and in three of the patients confirmed the diagnosis of dermatitis herpetiformis. Laboratory findings and upper gastrointestinal video endoscopy with biopsy were compatible in every case with celiac disease. Gluten-free diet in all patients indicated, one of them was enough to achieve complete remission of lesions after three months; the remaining three required starting dapsone for disease control (AU)

Bullous Dermatitis and Skin Necrosis Developing after Adrenalin Extravasation.

Extravasation of vasopressors can have serious complications varying from simple local reactions to skin necrosis and compartment syndrome. Here, we presented bullous dermatitis and skin necrosis which developed due to extravasation of adrenalin infusion in a Hodgkin lymphoma patient with septic shock who was admitted due febrile neutropenia.

Penfigoide bolhoso induzido por enalapril / Bullous pemphigoid induced by enalapril

O penfigoide bolhoso (PB) é uma dermatose bolhosa autoimune subepidérmica que comumente afeta indivíduos idosos. O desencadeamento da doença por medicamentos é conhecido, entretanto, pouco descrito na literatura, especialmente casos associados ao uso de enalapril. A interrupção do fármaco desencadeante constitui o pilar terapêutico, entretanto medicações podem ser necessárias. Descrevemos um caso de PB em um paciente com 45 anos associado ao uso do enalapril e discutimos sobre a variante de PB induzida por medicamentos.